Rubicon Organics Inc. (ROMJ.V)
CAD 0.4
(-1.25%)
CAD 0.4
(-1.25%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 14.22 Million CAD | -13.24% |
| 2022 | 16.39 Million CAD | 10.42% |
| 2021 | 14.84 Million CAD | 21.15% |
| 2020 | 12.25 Million CAD | 14.71% |
| 2019 | 10.68 Million CAD | -15.09% |
| 2018 | 12.58 Million CAD | 137.12% |
| 2017 | 5.3 Million CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.49 Million CAD | -2.6% |
| 2024 Q1 | 4.03 Million CAD | 30.76% |
| 2023 Q4 | 3.08 Million CAD | -10.29% |
| 2023 Q2 | 4.15 Million CAD | 19.61% |
| 2023 FY | 13.92 Million CAD | -15.05% |
| 2023 Q1 | 3.47 Million CAD | -28.34% |
| 2023 Q3 | 3.44 Million CAD | -17.16% |
| 2022 Q2 | 4.12 Million CAD | 14.04% |
| 2022 Q3 | 3.8 Million CAD | -7.92% |
| 2022 FY | 16.39 Million CAD | 10.42% |
| 2022 Q1 | 3.61 Million CAD | 1.88% |
| 2022 Q4 | 4.84 Million CAD | 27.5% |
| 2021 FY | 14.84 Million CAD | 21.15% |
| 2021 Q4 | 3.55 Million CAD | -2.96% |
| 2021 Q3 | 3.66 Million CAD | -12.96% |
| 2021 Q2 | 4.2 Million CAD | 22.71% |
| 2021 Q1 | 3.42 Million CAD | -13.22% |
| 2020 Q3 | 3.42 Million CAD | 61.78% |
| 2020 Q2 | 2.11 Million CAD | -8.58% |
| 2020 FY | 12.25 Million CAD | 14.71% |
| 2020 Q1 | 2.31 Million CAD | 460.03% |
| 2020 Q4 | 3.94 Million CAD | 15.18% |
| 2019 FY | 10.68 Million CAD | -15.09% |
| 2019 Q4 | -643.99 Thousand CAD | -113.36% |
| 2019 Q3 | 4.82 Million CAD | 31.86% |
| 2019 Q2 | 3.65 Million CAD | 28.22% |
| 2019 Q1 | 2.85 Million CAD | -27.73% |
| 2018 Q4 | 3.94 Million CAD | 12.77% |
| 2018 FY | 12.58 Million CAD | 137.12% |
| 2018 Q1 | 2.43 Million CAD | 99.36% |
| 2018 Q2 | 1.74 Million CAD | -28.51% |
| 2018 Q3 | 3.49 Million CAD | 101.04% |
| 2017 FY | 5.3 Million CAD | 0.0% |
| 2017 Q4 | 1.22 Million CAD | 0.81% |
| 2017 Q3 | 1.21 Million CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 2.96 Million CAD | -379.908% |
| CanadaBis Capital Inc. | 7.1 Million CAD | -100.149% |
| Decibel Cannabis Company Inc. | 40.44 Million CAD | 64.832% |
| Delivra Health Brands Inc. | 7.1 Million CAD | -100.087% |
| Entourage Health Corp. | 3.7 Million CAD | -283.64% |
| Lifeist Wellness Inc. | 17.59 Million CAD | 19.154% |
| Cannara Biotech Inc. | 15.34 Million CAD | 7.291% |
| Medicure Inc. | 13.98 Million CAD | -1.681% |
| PharmaCielo Ltd. | 8.33 Million CAD | -70.716% |
| BioSyent Inc. | 17.6 Million CAD | 19.219% |
| Voyageur Pharmaceuticals Ltd. | 1.22 Million CAD | -1065.01% |